Patents by Inventor Viviane Tabar

Viviane Tabar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF BRAIN CANCERS USING CENTRAL NERVOUS SYSTEM MEDIATED GENE TRANSFER OF MONOCLONAL ANTIBODIES
    Publication number: 20210171656
    Abstract: The invention provides methods to inhibit or treat brain cancers by locally inhibiting expression or activity of growth factors or growth factor receptors.
    Type: Application
    Filed: July 13, 2020
    Publication date: June 10, 2021
    Inventors: Ronald G. Crystal, Stephen M. Kaminsky, Martin J. Hicks, Viviane Tabar
  • DERIVATION OF SOMATOTROPHS FROM STEM CELLS AND USES THEREOF
    Publication number: 20200332253
    Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of stem cells (e.g., human stem cells) into somatotrophs, and differentiated cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating growth hormone deficiency.
    Type: Application
    Filed: May 7, 2020
    Publication date: October 22, 2020
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Viviane Tabar, Jinghua Piao
  • THIENOPYRIMIDINES AND USES THEREOF
    Publication number: 20200255447
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Application
    Filed: January 6, 2020
    Publication date: August 13, 2020
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato
  • Thienopyrimidines and uses thereof
    Patent number: 10526341
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: January 7, 2020
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato
  • THIENOPYRIMIDINES AND USES THEREOF
    Publication number: 20170355711
    Abstract: Described herein are thienopyrimidine compounds of Formula (I), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the thienopyrimidine compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., brain tumors such as DIPGs) in a subject. The invention further provides an embryonic stem cell-based tumor cell model, which can be used for drug screening and disease target identification.
    Type: Application
    Filed: November 19, 2015
    Publication date: December 14, 2017
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Viviane Tabar, Kosuke Funato
  • Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
    Publication number: 20030036195
    Abstract: The present invention provides methods of preparing mammalian cells and tissues for therapeutic and diagnostic purposes that are derived from ntES cells. The present invention further provides the mammalian cells and tissues themselves. In addition, methods of using the mammalian cells and tissues as a therapeutic agent or as a diagnostic are provided.
    Type: Application
    Filed: April 22, 2002
    Publication date: February 20, 2003
    Inventors: Lorenz Studer, Viviane Tabar, Peter Mombaerts, Teruhiko Wakayama, Anthony Perry